Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 33Recruiting 16Terminated 10Unknown 8Active not recruiting 8Withdrawn 6Not yet recruiting 4

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 7Tumor-Agnostic 5Thoracic 5Genitourinary 4Head & Neck 2Dermatologic 2Sarcoma 1Other hematologic neoplasm 1Classical hematology 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 220Urinary Bladder Neoplasms 54Carcinoma, Renal Cell 52Neoplasms 27Non-Muscle Invasive Bladder Neoplasms 26Kidney Neoplasms 25Breast Neoplasms 17Carcinoma, Transitional Cell 16Adenocarcinoma 15Melanoma 11Disease 11Neoplasm Metastasis 10Colorectal Neoplasms 10Uterine Cervical Neoplasms 9Endometrial Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Stomach Neoplasms 7Ovarian Neoplasms 7Lung Neoplasms 7Triple Negative Breast Neoplasms 6Testicular Neoplasms 6Recurrence 6Clear-cell metastatic renal cell carcinoma 6Urologic Neoplasms 5Urinary Incontinence 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Pancreatic Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Hepatocellular 5

Interventions

pemigatinib 1Pluvicto 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma × Genitourinary × Clear all
NCT07574541 2026-06-05

Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

National Institutes of Health Clinical Center (CC)

Phase 2 Not yet recruiting
52 enrolled
Genitourinary

Adenocarcinoma, Carcinoma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Prostatic Neoplasms

NCT07587814 2026-05-14

COCORIVO

Centre Henri Becquerel

Phase NA Not yet recruiting
100 enrolled
Genitourinary

Carcinoma, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT07231809 2026-05-06

HIVEC

AC.TA. S.r.l.

Phase NA Not yet recruiting
50 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma

NCT06551896 2024-08-13

Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting
30 enrolled
BreastGastrointestinalGenitourinarySarcomaThoracic

Breast Neoplasms, Carcinoma, Carcinoma, Transitional Cell, Lung Neoplasms, Sarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡